Funder: National Institutes of Health
Due Dates: June 16, 2025 (New/Renewal/Resubmission/Revision) | October 14, 2025 (New/Renewal/Resubmission/Revision) | February 17, 2026 (New/Renewal/Resubmission/Revision) | June 15, 2026 (New/Renewal/Resubmission/Revision) | October 14, 2026 (New/Renewal/Resubmission/Revision)
Funding Amounts: Up to $100,000/year (K99 mentored phase salary) + $30,000/year research costs; up to $249,000/year (R00 independent phase, total costs); max 5 years (2 years K99, 3 years R00)
Summary: Supports early-stage postdoctoral researchers in cancer-related basic experimental studies with humans, facilitating transition to independent faculty positions.
Key Information: Applicants must have ≤2 years postdoc experience; institutional nomination required; only one nominee per scientific area per institution per cycle.